Brent Johnson - Net Worth and Insider Trading

Brent Johnson Net Worth

The estimated net worth of Brent Johnson is at least $155,018 dollars as of 2024-05-30. Brent Johnson is the Exec. VP of WW Sales and Mktg of iRadimed Corp and owns about 3,663 shares of iRadimed Corp (IRMD) stock worth over $155,018. Details can be seen in Brent Johnson's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Brent Johnson has not made any transactions after 2020-04-09 and currently still holds the listed stock(s).

Transaction Summary of Brent Johnson

To

Brent Johnson Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Brent Johnson owns 1 companies in total, including iRadimed Corp (IRMD) .

Click here to see the complete history of Brent Johnson’s form 4 insider trades.

Insider Ownership Summary of Brent Johnson

Ticker Comapny Transaction Date Type of Owner
IRMD iRadimed Corp 2020-04-09 Exec. VP. Sales & Marketing

Brent Johnson Latest Holdings Summary

Brent Johnson currently owns a total of 1 stock. Brent Johnson owns 3,663 shares of iRadimed Corp (IRMD) as of April 9, 2020, with a value of $155,018.

Latest Holdings of Brent Johnson

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
IRMD iRadimed Corp 2020-04-09 3,663 42.32 155,018

Holding Weightings of Brent Johnson


Brent Johnson Form 4 Trading Tracker

According to the SEC Form 4 filings, Brent Johnson has made a total of 56 transactions in iRadimed Corp (IRMD) over the past 5 years, including 0 buys and 56 sells. The most-recent trade in iRadimed Corp is the sale of 4,000 shares on April 9, 2020, which brought Brent Johnson around $80,440.

Insider Trading History of Brent Johnson

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Brent Johnson Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Brent Johnson Ownership Network

Ownership Network List of Brent Johnson

No Data

Ownership Network Relation of Brent Johnson


Brent Johnson Owned Company Details

What does iRadimed Corp do?

Who are the key executives at iRadimed Corp?

Brent Johnson is the Exec. VP. Sales & Marketing of iRadimed Corp. Other key executives at iRadimed Corp include director & 10 percent owner & CEO & President & Chairman Roger E. Susi , Chief Financial Officer John Glenn , and CHIEF FINANCIAL OFFICER & SECR Christopher K. Scott .

iRadimed Corp (IRMD) Insider Trades Summary

Over the past 18 months, Brent Johnson made no insider transaction in iRadimed Corp (IRMD). Other recent insider transactions involving iRadimed Corp (IRMD) include a net sale of 450,000 shares made by Roger E. Susi , a net sale of 20,000 shares made by James B Hawkins , and a net sale of 4,055 shares made by Anthony Vuoto .

In summary, during the past 3 months, insiders sold 0 shares of iRadimed Corp (IRMD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 476,841 shares of iRadimed Corp (IRMD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 476,841 shares.

iRadimed Corp (IRMD)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

iRadimed Corp Insider Transactions

No Available Data

Brent Johnson Mailing Address

Above is the net worth, insider trading, and ownership report for Brent Johnson. You might contact Brent Johnson via mailing address: 4900 Hopyard Rd, Suite 210, Pleasitan Ca 94588.

Discussions on Brent Johnson

No discussions yet.